Pyridoxine and Innohep drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pyridoxine (pyridoxine (vitamin b6)) and Innohep (tinzaparin sodium). Common drug interactions include eczema among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Pyridoxine and Innohep. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Pyridoxine?

Pyridoxine has active ingredients of pyridoxine (vitamin b6). eHealthMe is studying from 8,747 Pyridoxine users. Check the latest studies of Pyridoxine.

What is Innohep?

Innohep has active ingredients of tinzaparin sodium. eHealthMe is studying from 9,243 Innohep users. Check the latest studies of Innohep.



On Jul, 17, 2026

33 people who take Pyridoxine and Innohep together, and have interactions are studied.

Pyridoxine and Innohep drug interactions.

What are the common drug interactions of Pyridoxine and Innohep, by gender? *:

female:

  1. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Back pain
  4. Dry skin
  5. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  6. Pain in extremity
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Spinal cord infection

male:

  1. Anaemia (lack of blood)
  2. Bone marrow failure
  3. Haemorrhoid operation
  4. Anal haemorrhage
  5. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  6. Benign prostatic hyperplasia (benign enlargement of the prostate)
  7. C-reactive protein increased
  8. Cerebral microangiopathy (small-vessel disease of brain)
  9. Conjunctivitis (pink eye)
  10. Cubital tunnel syndrome (a condition brought on by increased pressure on the ulnar nerve at the elbow)

What are the common drug interactions of Pyridoxine and Innohep, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  2. Drug level increased
  3. Hepatocellular injury (liver injury)
  4. Lactic acidosis (low ph in body tissues)

20-29:

n/a

30-39:

n/a

40-49:

  1. Dysphagia (a condition in which swallowing is difficult or painful)

50-59:

  1. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  2. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  3. Back pain
  4. Dry skin
  5. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  6. Pain in extremity
  7. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  8. Pulmonary embolism (blockage of the main artery of the lung)
  9. Sepsis (a severe blood infection that can lead to organ failure and death)
  10. Spinal cord infection

60+:

  1. Jugular vein thrombosis (clot in jugular vein)
  2. Venous thrombosis (blood clot (thrombus) that forms within a vein)
  3. Haemorrhoid operation
  4. Weight decreased
  5. Intermittent claudication
  6. Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
  7. Anal haemorrhage
  8. Arteriosclerosis coronary artery (thickening and hardening of arteries- coronary artery)
  9. Benign prostatic hyperplasia (benign enlargement of the prostate)
  10. C-reactive protein increased

What are the existing conditions these people have? *

  1. Depression: 16 people, 48.48%
  2. Short-Bowel Syndrome (a condition in which the body cannot absorb enough fluids and nutrients because part of the small intestine is missing): 16 people, 48.48%
  3. Back Pain: 15 people, 45.45%
  4. Oedema Peripheral (superficial swelling): 14 people, 42.42%
  5. Sepsis (a severe blood infection that can lead to organ failure and death): 14 people, 42.42%
  6. Hypoalbuminaemia (levels of albumin in blood serum are abnormally low): 14 people, 42.42%
  7. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 14 people, 42.42%
  8. Infection: 14 people, 42.42%
  9. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 14 people, 42.42%
  10. Svc Obstruction (superior vena cava obstruction (svco) is an uncommon complication of lung cancer): 14 people, 42.42%

* Approximation only. Some reports may have incomplete information.

Do you take Pyridoxine and Innohep?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pyridoxine and Innohep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pyridoxine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Innohep:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pyridoxine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Innohep and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on pyridoxine (vitamin b6) and tinzaparin sodium (the active ingredients of Pyridoxine and Innohep, respectively), and Pyridoxine and Innohep (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: